Sanofi's Dr Jack Prior detailed a data maturity framework for biologics manufacturing, while FDA and Gilead panelists debated risk-based AI validation.
Christopher Downey
Advertisement
Christopher Downey, PhD, is director of the Division of Pharmaceutical Manufacturing Assessment VI, OPMA, OPQ, and CDER at FDA.
Articles by Christopher Downey
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Adalvo Acquires Enzene’s Romiplostim Biosimilar Program for ITP
2
Merck and Kelun’s Sac-TMT Extends Survival by Nearly 7 Months in Pretreated Endometrial Cancer
3
BioNTech’s HER2 ADC Hits Phase 3 Goal, but Companies See Limited Benefit
4
The BioPharm Brief: Survival Gains, a Modest ADC Win, and CAR-T in Multiple Sclerosis
5